World's Best Scientists 2026 revealed!
Award Badge
Medicine
France
2023

D-Index & Metrics

Medicine

D-Index
129
Citations
65681
World Ranking
2581
National Ranking
1

Rolando Herrero publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Rolando Herrero sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 398 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Rolando Herrero D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Rolando Herrero sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 129 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in France Leader Award

Overview

Rolando Herrero is affiliated with the Costa Rican Agency for Biomedical Research and the INCIENSA Foundation in Costa Rica. Their research work primarily focuses on Medicine, with significant contributions across several specialized subfields including Epidemiology, Surgery, Computer Networks and Communications, Oncology, and Microbiology.

The scientist has extensively addressed topics related to Cervical Cancer and HPV Research, Hepatitis B Virus Studies, Helicobacter pylori-related gastroenterology studies, Head and Neck Cancer Studies, Global Cancer Incidence and Screening, Reproductive tract infections research, and IoT and Edge/Fog Computing.

Frequent co-authors in Rolando Herrero's publications include:

  • Carolina Porras
  • Allan Hildesheim
  • Aimée R. Kreimer
  • Bernal Cortés
  • John T. Schiller

The scientist has published regularly in several venues, with the most frequent being:

  • UNC Libraries
  • International Journal of Cancer
  • JNCI Journal of the National Cancer Institute
  • PLoS ONE
  • Vaccine

Recent papers by Rolando Herrero include:

  • Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis, 2022, The Lancet Global Health
  • Cervicovaginal microbiome and natural history of HPV in a longitudinal study, 2020, PLoS Pathogens
  • Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT Trial, 2020, JNCI Journal of the National Cancer Institute
  • Alcohol drinking and head and neck cancer risk: the joint effect of intensity and duration, 2020, British Journal of Cancer
  • Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial, 2020, The Lancet Oncology

Rolando Herrero has contributed to book publications as well, including a work published by Springer Science+Business Media titled "Fundamentals of IoT Communication Technologies" in 2021.

Best Publications

  • Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer

    Nubia Muñoz;F. Xavier Bosch;Silvia de Sanjosé;Rolando Herrero

  • Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.

    Rolando Herrero;Xavier Castellsagué;Michael Pawlita;Jolanta Lissowska

  • Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis.

    G. M. Clifford;S. Gallus;R. Herrero;N. Muñoz

  • Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium.

    Mia Hashibe;Paul Brennan;Shu Chun Chuang;Stefania Boccia

  • Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners

    Xavier Castellsagué;F. Xavier Bosch;Nubia Muñoz;Chris J.L.M. Meijer

  • Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study

    Victor Moreno;F Xavier Bosch;Nubia Muñoz;Chris J L M Meijer

  • Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study.

    Nubia Muñoz;Silvia Franceschi;Cristina Bosetti;Victor Moreno

  • Worldwide Human Papillomavirus Etiology of Cervical Adenocarcinoma and Its Cofactors: Implications for Screening and Prevention

    Xavier Castellsagué;Mireia Díaz;Silvia de Sanjosé;Nubia Muñoz

  • Epidemiology and molecular pathology of gallbladder cancer.

    Eduardo C. Lazcano-Ponce;J. F. Miquel;Nubia Muñoz;Rolando Herrero

  • Alcohol Drinking in Never Users of Tobacco, Cigarette Smoking in Never Drinkers, and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium

    Mia Hashibe;Paul Brennan;Simone Benhamou;Xavier Castellsague

  • Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica

    Rolando Herrero;Allan Hildesheim;Concepcion Bratti;Mark E. Sherman

  • Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial.

    Allan Hildesheim;Rolando Herrero;Sholom Wacholder;Ana C. Rodriguez

  • Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis

    Laia Bruni;Mireia Diaz;Leslie Barrionuevo-Rosas;Rolando Herrero

  • HPV DNA testing in cervical cancer screening. Results from women in a high-risk province of Costa Rica.

    Mark Schiffman;Rolando Herrero;Allan Hildesheim;Mark E. Sherman

  • The carcinogenicity of human papillomavirus types reflects viral evolution

    Mark Schiffman;Rolando Herrero;Rob DeSalle;Allan Hildesheim

  • Rapid Clearance of Human Papillomavirus and Implications for Clinical Focus on Persistent Infections

    Ana Cecilia Rodríguez;Mark Schiffman;Rolando Herrero;Sholom Wacholder

  • Herpes Simplex Virus-2 as a Human Papillomavirus Cofactor in the Etiology of Invasive Cervical Cancer

    Jennifer S. Smith;Rolando Herrero;Cristina Bosetti;Nubia Muñoz

  • A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica.

    Philip E. Castle;Mark Schiffman;Rolando Herrero;Allan Hildesheim

  • Effect of Human Papillomavirus 16/18 L1 Viruslike Particle Vaccine Among Young Women With Preexisting Infection

    Allan Hildesheim;Rolando Herrero;Sholom Wacholder;Ana C. Rodriguez

  • Population-based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica

    Rolando Herrero;Allan Hildesheim;Concepcion Bratte;Mark E. Sherman

Frequent Co-Authors

Mark Schiffman
Mark Schiffman National Institutes of Health
Allan Hildesheim
Allan Hildesheim National Institutes of Health
Silvia Franceschi
Silvia Franceschi Centro di Riferimento Oncologico
Robert D. Burk
Robert D. Burk Albert Einstein College of Medicine
Sholom Wacholder
Sholom Wacholder National Institutes of Health
Mark E. Sherman
Mark E. Sherman Mayo Clinic
Nubia Muñoz
Nubia Muñoz International Agency For Research On Cancer
Xavier Castellsagué
Xavier Castellsagué University of Barcelona
Chris J.L.M. Meijer
Chris J.L.M. Meijer Vrije Universiteit Amsterdam
Paolo Boffetta
Paolo Boffetta Stony Brook Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens up many educational paths beyond the traditional MD route. For those seeking flexibility, online nursing degrees are increasingly popular. For registered nurses, there are online rn to bsn no clinicals programs that remove the need for in-person clinicals, making it easier to balance work and study.

Advanced practice nurses and those looking to move into leadership can benefit from the quickest dnp program options. These programs allow you to earn a Doctor of Nursing Practice credential in less time and often more conveniently online.

Cost can also be a concern. Many students seek out affordable dnp programs that offer quality education without the hefty price tag. This makes further advancement both accessible and practical.

Even those just starting their nursing journey have fast options. accelerated lpn programs can quickly launch your healthcare career and serve as a stepping stone toward future degrees.

Whether upgrading credentials or beginning your healthcare path, these online options help bridge the gap between ambition and opportunity in the US medical field.

Best Scientists Citing Rolando Herrero

Trending Scientists

Recently Published Articles